Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19

Pharmacological Research(2024)10.1016/j.phrs.2024.107170Source: DataRank Database

SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19 is a research paper published in Pharmacological Research (2024). On theSindex it has a DataRank of 0. It has been cited 44 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access44 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 7.47)OA: goldTopics (44)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Jeffrey Haltom ORCID,Yentli E. Soto Albrecht ORCID,Timothy Lie,Arnold Z. Olali ORCID,Gabrielle A. Widjaja

Live enrichment

PubMed:38614374 OpenAlex:https://openalex.org/W4394796305

National Institutes of Health

Grant: AG078814and CA259635

National Institutes of Health

Grant: CA259635

U.S. Department of Defense

Grant: W81XWH-21-1-0128

Bill and Melinda Gates Foundation

Grant: INV-046722

NIA NIH HHS

Grant: R01 AG078814

NCI NIH HHS

Grant: R01 CA259635

FWCI

7.47

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.phrs.2024.107170

publisherhttps://doi.org/10.1016/j.phrs.2024.107170

publisherhttps://api.elsevier.com/content/article/PII:S1043661824001142?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1043661824001142?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38614374

Fields of Study

Mitochondrial Function and PathologyAutophagy in Disease and TherapyLong-Term Effects of COVID-19HumansCOVID-19SARS-CoV-2MitochondriaOxidative PhosphorylationReactive Oxygen SpeciesEpigenesis, GeneticEnergy MetabolismEpigenomicsAnimals

MeSH Terms

COVID-19SARS-CoV-2AnimalsEnergy MetabolismHumansMitochondriaOxidative PhosphorylationReactive Oxygen SpeciesEpigenesis, GeneticEpigenomics

Keywords

BiologyEpigenomeCell biologyMitochondrial DNAOxidative phosphorylationMitochondrial biogenesisMitochondrionTFAMReprogrammingGlycolysisBiochemistryGene expressionDNA methylationMetabolismCellGeneGene regulationInhibitorsMitochondriaOXPHOSSARS-CoV-2

Sustainable Development Goals

SDG 0: Affordable and clean energy